Imagine living with a condition that not only affects your joints but also puts your kidneys at risk. That's the reality for many people with lupus nephritis, a serious complication of systemic lupus erythematosus. Treating this condition can be challenging, and current therapies don't always work well enough. Now, a new clinical trial is exploring whether cenerimod, a medication taken alongside regular treatments, can improve kidney function in adults with active lupus nephritis. Over 76 weeks, participants will take either cenerimod or a placebo—an inactive substitute—while regularly visiting the clinic for checkups. The hope is that cenerimod will lead to a complete renal response, meaning improved kidney health. If this trial shows positive results, it could offer new hope for lupus patients struggling with kidney issues. However, it’s important to remember that not all treatments work for everyone, and this trial is still in the early stages. Patients interested in participating should discuss it with their healthcare provider to understand the potential risks and benefits.
Could a New Drug Help Improve Kidney Function in Lupus Patients?
Plain Language Summary
What this means for you:
A new drug may offer hope for lupus patients by improving kidney function and overall health. What this means for you:
A new drug may offer hope for lupus patients by improving kidney function and overall health. View Original Abstract ↓
Status: RECRUITING | Phase: PHASE3
Condition(s): Nephritis, Lupus, Lupus Erythematosus, Systemic
Intervention(s): Cenerimod (DRUG), Placebo (DRUG)
The goal of this clinical trial is to learn if cenerimod, on top of regular treatment, works to treat active lupus nephritis in adults with systemic lupus erythematosus and active lupus nephritis. It will also learn about the safety of cenerimod. The main questions it aims to answer are:
* Does cenerimod improve kidney function in participants?
* What medical problems do participants have when taking cenerimod?
Researchers will compare cenerimod to a placebo (a look-alike substance that contains no drug) to see how well cenerimod works when it is added to regular treatment.
Participants will:
* Take cenerimod or a placebo every day for 76 weeks (approximately 1.5 years), on top of regular treatment.
* Visit the clinic every 1 to 3 months for checkups and tests.
Primary Outcome(s): Complete renal response (CRR)
Enrollment: 300 (ESTIMATED)
Lead Sponsor: Viatris Innovation GmbH
Start: 2026-02-09 | Primary Completion: 2029-08